Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ANVS
ANVS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ANVS News
Annovis Bio Regains NYSE Compliance Ahead of Schedule
3d ago
NASDAQ.COM
Annovis Bio Restores Compliance with NYSE Listing Standards
4d ago
seekingalpha
Annovis Bio Inc. Prices Public Offering to Raise $15 Million
May 21 2026
NASDAQ.COM
Annovis Bio's Stock Drops After $15M Offering Announcement
May 20 2026
seekingalpha
Annovis Bio Announces Public Offering for Neurodegenerative Drug Development
May 20 2026
NASDAQ.COM
Annovis Bio Launches Proposed Public Offering
May 19 2026
seekingalpha
Annovis Biopress Reports Q1 Losses and Cash Decline
May 15 2026
seekingalpha
Annovis Bio to Present at Fierce Biotech Week 2026
May 07 2026
Newsfilter
Annovis Bio Secures Financing for Alzheimer's Drug Development
Apr 10 2026
Newsfilter
Annovis Bio Prices Underwritten Offering for $10 Million
Apr 09 2026
Newsfilter
Biotech IPOs Show Strong Performance in Q1 2026
Apr 08 2026
Newsfilter
Annovis Bio and Vale Executives Increase Stock Holdings
Apr 06 2026
NASDAQ.COM
Annovis Bio Secures New Patent, Shares Rise 17%
Apr 06 2026
NASDAQ.COM
Annovis Bio Secures New Patent for Buntanetap
Apr 02 2026
Newsfilter
NeuroRPM Partners with Annovis for Parkinson's Disease Monitoring
Mar 19 2026
Globenewswire
Annovis Biopress Reports FY GAAP EPS of -$1.40
Mar 16 2026
seekingalpha
Show More News
